Johannes Doll
Chief Executive Officer at SEDANA MEDICAL AB
Net worth: 242 742 $ as of 2024-04-29
Network origin in Johannes Doll first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
24
| Public Company | Pharmaceuticals: Major | 24 |
| Public Company | Medical Specialties | 19 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Johannes Doll via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| JUNIPER PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Chairman | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| TELE2 AB | Major Telecommunications | Director of Finance/CFO | |
| AEROCRINE AB | Electronic Equipment/Instruments | Chairman Chief Executive Officer | |
| TRILLIUM THERAPEUTICS | Biotechnology | Director/Board Member | |
Ironshore Therapeutics, Inc.
 Ironshore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ironshore Therapeutics, Inc. operates as a pharmaceutical company. The firm offers HLD-200, HLD-900, the morning routine and the delexis products. It develops commercialization of a proprietary drug delivery system. The company was founded by David Gordon MacLeod Lickrish in 2008 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Chairman | |
| UCB | Pharmaceuticals: Major | Corporate Officer/Principal | |
| COLOPLAST A/S | Medical Specialties | Corporate Officer/Principal | |
| ALFA LAVAL AB | Industrial Machinery | Corporate Officer/Principal | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
Atos Medical AB
 Atos Medical AB Medical SpecialtiesHealth Technology Atos Medical AB engages in the development and manufacture of medical products for the ear, nose, and throat areas. The firm provides solutions to people who breathe through a stoma. It offers a range of voice- and pulmonary rehabilitation devices, and provox products. The company was founded by Gert Persson and Jan-Ove Persson in 1986 and is headquartered in Malmo, Sweden. | Medical Specialties | Chief Executive Officer | |
Systembolaget AB
 Systembolaget AB Specialty StoresRetail Trade Systembolaget AB sells alcoholic products properly; and informs drinkers about the alcohol-related problems. It also offers non-alcoholic beverages and its products include liquor, wines, and beers. The firm provides information on the harmful effects of alcohol, as well. The company was founded on October 1, 1955 and is headquartered in Stockholm, Sweden. | Specialty Stores | Director of Finance/CFO | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree | |
| University of London | College/University | Doctorate Degree Doctorate Degree | |
| Copenhagen Business School | College/University | Graduate Degree Graduate Degree | |
| Chalmers University of Technology | College/University | Graduate Degree | |
| Stockholm School of Economics | College/University | Masters Business Admin Undergraduate Degree Graduate Degree | |
| University of Uppsala | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Doctorate Degree | |
| The University of Sydney | College/University | Graduate Degree | |
| University of Stockholm | College/University | Graduate Degree Undergraduate Degree | |
| Royal Institute of Technology | College/University | Graduate Degree Graduate Degree Graduate Degree | |
Addici Holding AB
 Addici Holding AB Miscellaneous Commercial ServicesCommercial Services Addici Holding AB operates a holding company with interests in providing facility management. It offers services related to workplaces, personnal, customers, and real estate through Addici Facility Management AB. The company is headquartered in Bromma, Sweden. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Gothenburg | College/University | Graduate Degree | |
| MOBERG PHARMA AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Handelshögskolan i Göteborg | College/University | Masters Business Admin Graduate Degree | |
Coloplast AB
 Coloplast AB Medical DistributorsDistribution Services Coloplast AB develops and markets medical products and services. It focuses on the urinary and gastrointestinal tract systems. The company is headquartered in Kungsbacka, Sweden. | Medical Distributors | Corporate Officer/Principal | |
| SENSORION | Pharmaceuticals: Major | Chairman | |
Novo Principal Investments
 Novo Principal Investments Investment ManagersFinance Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Chief Executive Officer Private Equity Investor | |
| XVIVO PERFUSION AB | Medical Specialties | Chief Executive Officer | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer General Counsel | |
Ellab A/S
 Ellab A/S Electronic Equipment/InstrumentsElectronic Technology Ellab A/S engages in the provision of process validation and monitoring solutions used in the pharmaceutical, medical, and food industries. It offers calibration, training and consulting, qualification and validation, rental, and software support services. The company was founded by Jorgen Leo Nielsen in 1949 and is headquartered in Hillerod, Denmark. | Electronic Equipment/Instruments | Director/Board Member | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
| UCLA Anderson School of Management | College/University | Masters Business Admin | |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Chief Executive Officer | |
Banner Life Sciences LLC
 Banner Life Sciences LLC Pharmaceuticals: MajorHealth Technology Banner Life Sciences LLC operates as clinical-stage pharmaceutical company. The company is headquartered in High Point, NC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| HARPOON THERAPEUTICS, INC. | Biotechnology | Chairman | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Convergent Therapeutics, Inc.
 Convergent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Convergent Therapeutics, Inc. is a clinical stage pharmaceutical company located in Cambridge, MA. The company focuses on developing next generation radiopharmaceutical therapies for prostate and other cancers. The company's proprietary technology involves dual-targeted radionuclide therapy (RNT) developed by Dr. Neil Bander, a professor of urologic oncology at Weill Cornell Medicine and licensed to Convergent by Cornell University. The company's lead product candidate, Conv01-?, is a monoclonal antibody conjugated with actinium-225 (225Ac), a radioactive alpha particle emitter, designed to bind to the prostate-specific membrane antigen (PSMA). If FDA-approved, Conv01-? would be the first antibody approved to direct a radioisotope to prostate cancer, and the first drug approved for the use of 225Ac in a cancer treatment. The company was founded by Philip Wayne Kantoff and Neil H. Bander, and Philip Wayne Kantoff has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman | |
| Eden Investment LLC | Chief Executive Officer |
Statistics
International
| Sweden | 23 |
| United States | 17 |
| Denmark | 6 |
| Canada | 3 |
| Belgium | 2 |
Sectoral
| Health Technology | 21 |
| Consumer Services | 14 |
| Commercial Services | 7 |
| Electronic Technology | 3 |
| Communications | 2 |
Operational
| Director/Board Member | 178 |
| Corporate Officer/Principal | 76 |
| Independent Dir/Board Member | 53 |
| Chief Executive Officer | 49 |
| Chairman | 47 |
Most connected contacts
| Insiders | |
|---|---|
| James Noble | 39 |
| Maria Christina Schauman | 32 |
| Alf Gunnar Martin Nicklasson | 31 |
| Michael Shalmi | 30 |
| Hilde Furberg | 21 |
| Scott Myers | 18 |
| Ray Hill | 18 |
| David Colpman | 15 |
| George Frederick Wilkinson | 14 |
| Kjell Rudolf Peter Edman | 14 |
| Johan Laven | 13 |
| Eva Walde | 13 |
| Henrik Juuel | 12 |
| Dennis Urbaniak | 10 |
| Ola Gunnar Magnusson | 10 |
- Stock Market
- Insiders
- Johannes Doll
- Company connections
